Status:
UNKNOWN
Evaluation of the Effect of Immune Modulating Enteral Nutrition Formula
Lead Sponsor:
NewGiza University
Conditions:
Sepsis
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim is to compare the efficacy and tolerability of an immune modulating enteral nutrition formula versus the regular formula on the outcomes of critically ill septic patients by assessment of clin...
Detailed Description
Nutritional formulas are considered important sources of the dietary components that the body requires. They contain the sources of fats, proteins and carbohydrates and compensate any vitamin and mine...
Eligibility Criteria
Inclusion
- Diagnosed with sepsis according to guideline criteria AND
- Age ≥18 years
Exclusion
- Gastrointestinal tract complications or intestinal failure or any contraindications to receive enteral nutrition
- Hemodynamic instability on admission
Key Trial Info
Start Date :
October 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 28 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05186480
Start Date
October 3 2021
End Date
March 28 2022
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NewGizaU
Cairo, Egypt